HCMT
NERV icon

Highland Capital Management (Texas)’s Minerva Neurosciences NERV Stock Holding History

Highland Capital Management (Texas)’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$4.85M Hold
107,715
– – 0.28% 61
2019
Q1 		$6.77M Sell
107,715
-21,938
-17% -$1.32M 0.42% 48
2018
Q4 		$6.99M Sell
129,653
-35,250
-21% -$2.58M 0.54% 39
2018
Q3 		$16.6M Sell
164,903
-48,821
-23% -$3.67M 0.91% 24
2018
Q2 		$14.1M Sell
213,724
-67,136
-24% -$4.08M 0.8% 28
2018
Q1 		$14M Buy
280,860
+10,792
+4% +$519K 0.72% 29
2017
Q4 		$13.1M Buy
270,068
+27,830
+11% +$1.38M 0.6% 39
2017
Q3 		$14.7M Buy
242,238
+19,691
+9% +$1.13M 0.65% 38
2017
Q2 		$15.8M Sell
222,547
-82,518
-27% -$5.34M 0.67% 34
2017
Q1 		$19.8M Buy
305,065
+162,398
+114% +$12.6M 1.01% 24
2016
Q4 		$13.4M Sell
142,667
-22,799
-14% -$2.33M 0.63% 45
2016
Q3 		$18.7M Buy
165,466
+56,924
+52% +$5.52M 0.57% 40
2016
Q2 		$8.87M Sell
108,542
-2,592
-2% -$165K 0.36% 74
2016
Q1 		$5.46M Sell
111,134
-54,211
-33% -$2.31M 0.24% 109
2015
Q4 		$8.03M Buy
165,345
+8,125
+5% +$339K 0.26% 116
2015
Q3 		$6.6M Buy
157,220
+1,768
+1% +$81.2K 0.19% 129
2015
Q2 		$7.21M Buy
+155,452
New +$6.63M 0.15% 139
2014
Q4 		– Sell
-17,822
Closed -$863K – 246
2014
Q3 		$863K Buy
+17,822
New +$947K 0.03% 186

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IVAV
Index Venture Associates V St. Helier, Channel Islands, Jersey $1.46M AUM 88.05% 1-Year Est. Return

Highland Capital Management (Texas)'s NERV Position: Q2 2019 in Review

Highland Capital Management (Texas) held its Minerva Neurosciences (NERV) position steady in Q2 2019 at 107,715 shares worth $4.85M. The position accounts for 0.28% of the portfolio, ranked #61.

Highland Capital Management (Texas) first reported a position in NERV in Q3 2014 and has held it in 18 quarters since. The position peaked at $19.8M in Q1 2017. 85 funds tracked by Wall St. Rank hold NERV as of Q2 2019.

  • Highland Capital Management (Texas) held 107,715 shares of Minerva Neurosciences worth $4.85M as of Q2 2019.
  • Highland Capital Management (Texas) left its Minerva Neurosciences share count unchanged in Q2 2019.
  • Minerva Neurosciences made up 0.28% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #61 holding.
  • Highland Capital Management (Texas) first reported a position in Minerva Neurosciences in Q3 2014 and has held it in 18 quarters since.
  • Highland Capital Management (Texas)'s Minerva Neurosciences position peaked at $19.8M in Q1 2017.
  • 85 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.